Shorla Oncology partake in Indegene Digital Summit and speak with Dr. Scott Gottlieb, 23rd Commissioner of the FDA
Shorla Oncology Co-founder, Sharon Cunningham had the opportunity to speak to Dr. Scott Gottlieb, 23rd Commissioner of the FDA on October 2nd 2020. This was part of Indegene’s Digital Summit 2020 where Sharon participated in a panel discussion with other next-gen pharma/biotech CEOs on “The Challenges of Moving From x to 10x – Can Digital Accelerate the Journey”. Many thanks to Indegene for the invitation to this event and to the other panelists and host for the intriguing conversations on reimagining a digitally connected future for the industry.
